Article
Novartis AG v. Union of India & Others - Judgment
[full text of Supreme Court decision rejecting Novartis’ patent claim.]
Timeline
-
To patent or not to patent? the case of Novartis’ cancer drug Glivec in India
-
Patent wars: has India taken on Big Pharma and won?
-
5 Take-Home Points From India’s Historic Novartis Patent Case
-
Why Novartis case will help innovation [India]
-
India’s Patently Wise Decision
-
More battles in store [India]
-
Finally, the patients prevail [India]
-
Indian Supreme Court Delivers Verdict in Novartis Case
-
The Novartis Saga: a timeline [India]
-
Novartis AG v. Union of India & Others - Judgment
-
Landmark verdict gives big boost to cancer patients [India]
-
Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India
-
Analysis: Legal case in India threatens HIV drug access for poorest
-
En Inde, l'accès aux génériques suspendu à un procès
Available languages: français -
Indian drugs boss hails Aids deal
-
Novartis accusé de saper l’accès des pauvres aux médicaments [Inde]
Available languages: français -
World's poor still deprived of drugs - activists
View full case